Navigation Links
ev3 Inc. Reports Third Quarter 2008 Financial Results
Date:10/31/2008

venue of $21.0 million, peripheral vascular product sales increased 19% to $45.9 million in the third quarter of 2008 versus $38.7 million in the third quarter of 2007. Stent product sales increased 16% to $26.8 million from $23.1 million. Thrombectomy and embolic protection product sales increased 29% to $6.9 million from $5.4 million, while sales of procedural support and other peripheral vascular products increased 19% to $12.2 million from $10.2 million.

In the third quarter of 2008, ev3's neurovascular segment net sales increased 26% to $33.1 million versus $26.4 million in the third quarter of 2007. Within the neurovascular business segment, sales of embolic products increased 24% to $18.2 million from $14.7 million, and sales of neurovascular access and delivery products were up 28% to $14.9 million from $11.7 million.

Research collaboration revenue resulting from ev3's former collaboration and license agreement with Merck & Co., Inc. was $7.0 million for the third quarter of 2008, which included approximately $2.0 million for wind-down activities as negotiated with Merck. ev3 expects to recognize approximately $800,000 of additional revenue from wind-down activities in the fourth quarter of 2008.

On a geographic basis, when compared to the third quarter of 2007, ev3's third quarter 2008 U.S. net sales increased 84% to $70.4 million, while third quarter 2008 international net sales increased 37% to $36.6 million, over the prior-year quarter. ev3's third quarter 2008 U.S. net sales increase was primarily due to the FoxHollow acquisition. International sales growth was primarily due to the Axium coil, further market penetration of the EverFlex family of stents and the Onyx Liquid Embolic System for the treatment of brain arterio-venous malformations (AVMs), and the introduction of atherectomy products into international markets. Changes in foreign currency exchange rates had a positive impact of approximately $1.7 million on third quarter 2
'/>"/>

SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. eResearchTechnology Reports Third Quarter 2008 Results
2. Thoratec Reports 44 Percent Increase in Third Quarter Revenues
3. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
4. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
5. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. United Therapeutics Reports Third Quarter 2008 Financial Results
8. BioMed Realty Trust Reports Third Quarter 2008 Financial Results
9. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
10. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
11. VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... OTC Markets Group Inc. ... company, on its approval to list on The ... the best marketplace for established U.S. and global ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We ... its growth strategy and achievement of this important ...
(Date:8/21/2014)... August 21, 2014 Pursuit Solutions ... optimization technology and services for Life Sciences sales ... Pharma’s Use of New Commercial Sales Models” by ... Analytics. , The article examines some innovative models ... are being tested in the pharmaceutical market. Robinson ...
(Date:8/21/2014)... Boston, MA (PRWEB) August 21, 2014 ... collaboration company, has been recognized as one of ... 500 | 5000 magazine for the 2nd consecutive ... on its 33rd annual Inc. 500|5000, an exclusive ... list represents the most comprehensive look at the ...
(Date:8/20/2014)... inventions licensed to biotechnology firms has revealed early ... these roadblocks, the researchers suggest that better communication ... could lead to faster commercialization down the road. ... made in university laboratories and licensed to biotechnology ... which have a high failure rate. But a ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... , NINGBO, China , ... Equipment Co., Ltd. (TAIJI),s FGD (Flue-gas desulfurization),technology was officially ... For the project, TAIJI chose to use steel slag ... used in desulfurization. In,comparison to the use of lime ...
... Mass. , May 18 , ... What: Virtify, ... solutions, will co-host the webinar, "Managing Paper at Its Roots: Extending ... how emerging ECC solutions are accelerating traditional document preparation by compressing ...
... HALMSTAD, Sweden , May 18, 2010 , ... - With Photo , ... The Redsense safety device is now cleared by FDA for Home/Self ... is designed to detect venous needle dislodgement,during hemodialysis and its use has already improved in-clinic ...
Cached Biology Technology:TAIJI Announces Official Operation of Its Sintering FGD Project for Tangshan 2Webinar Alert: 'Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance' 2Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis 2
(Date:8/21/2014)... the journal Carcinogenesis by researchers at the ... protein adenomatous polyposis coli (APC) in suppressing colorectal cancer ... U.S. , Lead author Kristi Neufeld, associate professor in ... Cancer Biology program at the KU Cancer Center, has ... understand the various activities of APC, a protein whose ...
(Date:8/21/2014)... successfully replicated one of the crucial steps in photosynthesis, ... which could manufacture hydrogen as a fuel. , "Water ... exciting prospect to use them to create hydrogen, and ... from the ARC Centre of Excellence for Translational Photosynthesis ... offers potential as a zero-carbon replacement for petroleum products, ...
(Date:8/20/2014)... 2014 George E. Fox, a John and Rebecca Moores ... (UH), was named a fellow in the International Society for ... Fox is one of four members two from the ... as fellows in 2014. Fellows are elected every three years, ... 500 members from more than 20 countries, the ISSOL includes ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Water and sunlight the formula for sustainable fuel 2UH professor named fellow by International Astrobiology Society 2
... America. Their geographical distribution extends from the Orinoco River ... the Paran (Argentina) to the South. Over this whole ... have recorded 28 carnivorous species of these fish (2). ... of fish, the mechanisms that generated the species richness ...
... appearing in the Dec. 2007 Journal of Lipid Research ... Affect Diet-Associated Cholesterol Metabolism, Crohns Disease Increases Progression of ... , Genetic Variants Affect ... variants in two metabolic genes alter how the body ...
... WHAT: The 2007 American College of Neuropsychopharmacology Annual ... and behavior from the worlds leading scientists. Presentations ... post-traumatic stress disorder, autism and addiction. ... Link between Cancer and Schizophrenia A series of studies ...
Cached Biology News:Present-day species of piranha result from a marine incursion into the Amazon Basin 2Present-day species of piranha result from a marine incursion into the Amazon Basin 3Story ideas from the Journal of Lipid Research 2Story ideas from the Journal of Lipid Research 3New studies on schizophrenia, depression, trauma and autism highlight annual meeting 2New studies on schizophrenia, depression, trauma and autism highlight annual meeting 3
... variety of environmental and pathophysiological stressful conditions ... proteins known as heat shock proteins (HSPs), ... (SRPs). The Hsp90 family of proteins ... and beta, Grp94, and Trap-1 (Hsp75). It ...
... (AR) Competitor Assay Kits provide a sensitive ... potential AR ligands using fluorescence polarization (FP). ... domain protein tagged with His and GST ... androgen ligand (Fluormone AL Green in the ...
Custom LNA Oligonucleotide synthesis ,High quality Custom LNA Oligonucleotides are available for a variety of different specialty applications and innovative products. ,Please inquire for further...
... - with a modular approach to instrument ... ChemStation Plus NDS family provides modular software ... data management, giving you the flexibility to ... needs now and that can grow as ...
Biology Products: